Annual Net Income
-$209.25 M
+$24.41 M+10.45%
31 December 2023
Summary:
Esperion Therapeutics annual net profit is currently -$209.25 million, with the most recent change of +$24.41 million (+10.45%) on 31 December 2023. During the last 3 years, it has fallen by -$65.70 million (-45.77%). ESPR annual net income is now -1861.09% below its all-time high of -$10.67 million, reached on 31 December 1999.ESPR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$29.52 M
+$32.40 M+52.32%
30 September 2024
Summary:
Esperion Therapeutics quarterly net profit is currently -$29.52 million, with the most recent change of +$32.40 million (+52.32%) on 30 September 2024. Over the past year, it has increased by +$11.73 million (+28.43%). ESPR quarterly net income is now -123.69% below its all-time high of $124.61 million, reached on 30 June 2020.ESPR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$86.77 M
+$11.73 M+11.90%
30 September 2024
Summary:
Esperion Therapeutics TTM net profit is currently -$86.77 million, with the most recent change of +$11.73 million (+11.90%) on 30 September 2024. Over the past year, it has increased by +$121.62 million (+58.36%). ESPR TTM net income is now -3443.12% below its all-time high of -$2.45 million, reached on 31 March 2012.ESPR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.4% | +28.4% | +58.4% |
| 3 y3 years | -45.8% | +57.5% | +71.9% |
| 5 y5 years | -3.7% | +56.8% | +8.9% |
ESPR Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -45.8% | +22.2% | -148.4% | +57.5% | -0.3% | +71.9% |
| 5 y | 5 years | -115.3% | +22.2% | -123.7% | +71.7% | -3.4% | +73.3% |
| alltime | all time | -1861.1% | +22.2% | -123.7% | +71.7% | -3443.1% | +73.3% |
Esperion Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$29.52 M(-52.3%) | -$86.77 M(-11.9%) |
| June 2024 | - | -$61.92 M(-201.5%) | -$98.50 M(+13.9%) |
| Mar 2024 | - | $61.02 M(-208.3%) | -$86.51 M(-58.7%) |
| Dec 2023 | -$209.25 M(-10.4%) | -$56.34 M(+36.6%) | -$209.25 M(+0.4%) |
| Sept 2023 | - | -$41.25 M(-17.4%) | -$208.39 M(-6.2%) |
| June 2023 | - | -$49.94 M(-19.1%) | -$222.26 M(-6.9%) |
| Mar 2023 | - | -$61.72 M(+11.2%) | -$238.65 M(+2.1%) |
| Dec 2022 | -$233.66 M(-13.2%) | -$55.49 M(+0.7%) | -$233.66 M(-4.0%) |
| Sept 2022 | - | -$55.12 M(-16.9%) | -$243.29 M(-5.5%) |
| June 2022 | - | -$66.32 M(+16.9%) | -$257.56 M(+9.6%) |
| Mar 2022 | - | -$56.73 M(-12.9%) | -$234.90 M(-12.7%) |
| Dec 2021 | -$269.11 M(+87.5%) | -$65.12 M(-6.1%) | -$269.11 M(-12.8%) |
| Sept 2021 | - | -$69.39 M(+58.9%) | -$308.46 M(-4.9%) |
| June 2021 | - | -$43.67 M(-52.0%) | -$324.52 M(+107.7%) |
| Mar 2021 | - | -$90.94 M(-13.0%) | -$156.24 M(+8.8%) |
| Dec 2020 | -$143.55 M(+47.7%) | -$104.48 M(+22.3%) | -$143.55 M(+42.1%) |
| Sept 2020 | - | -$85.44 M(-168.6%) | -$101.02 M(+20.3%) |
| June 2020 | - | $124.61 M(-259.2%) | -$83.96 M(-68.1%) |
| Mar 2020 | - | -$78.25 M(+26.3%) | -$262.79 M(+170.5%) |
| Dec 2019 | -$97.17 M(-51.9%) | -$61.95 M(-9.4%) | -$97.17 M(+2.0%) |
| Sept 2019 | - | -$68.38 M(+26.1%) | -$95.26 M(+24.0%) |
| June 2019 | - | -$54.22 M(-162.1%) | -$76.79 M(+12.4%) |
| Mar 2019 | - | $87.38 M(-245.5%) | -$68.30 M(-66.2%) |
| Dec 2018 | -$201.81 M(+20.9%) | -$60.04 M(+20.3%) | -$201.81 M(+12.3%) |
| Sept 2018 | - | -$49.91 M(+9.1%) | -$179.66 M(+2.7%) |
| June 2018 | - | -$45.73 M(-0.9%) | -$174.97 M(+1.4%) |
| Mar 2018 | - | -$46.13 M(+21.7%) | -$172.58 M(+3.3%) |
| Dec 2017 | -$166.99 M | -$37.89 M(-16.2%) | -$166.99 M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$45.22 M(+4.3%) | -$158.05 M(+21.4%) |
| June 2017 | - | -$43.34 M(+6.9%) | -$130.24 M(+29.0%) |
| Mar 2017 | - | -$40.54 M(+40.0%) | -$100.93 M(+34.6%) |
| Dec 2016 | -$74.98 M(+50.6%) | -$28.96 M(+66.4%) | -$74.98 M(+26.8%) |
| Sept 2016 | - | -$17.40 M(+24.0%) | -$59.14 M(+8.4%) |
| June 2016 | - | -$14.04 M(-3.8%) | -$54.54 M(+3.1%) |
| Mar 2016 | - | -$14.59 M(+11.1%) | -$52.90 M(+6.3%) |
| Dec 2015 | -$49.78 M(+36.9%) | -$13.12 M(+2.5%) | -$49.78 M(+7.9%) |
| Sept 2015 | - | -$12.80 M(+3.3%) | -$46.12 M(+6.9%) |
| June 2015 | - | -$12.39 M(+8.1%) | -$43.12 M(+7.9%) |
| Mar 2015 | - | -$11.47 M(+21.2%) | -$39.97 M(+9.9%) |
| Dec 2014 | -$36.38 M(+39.4%) | -$9.46 M(-3.6%) | -$36.38 M(-0.6%) |
| Sept 2014 | - | -$9.81 M(+6.1%) | -$36.61 M(+14.3%) |
| June 2014 | - | -$9.24 M(+17.3%) | -$32.04 M(+7.8%) |
| Mar 2014 | - | -$7.87 M(-18.7%) | -$29.72 M(+13.9%) |
| Dec 2013 | -$26.09 M(+122.2%) | -$9.69 M(+85.0%) | -$26.09 M(+36.1%) |
| Sept 2013 | - | -$5.24 M(-24.3%) | -$19.17 M(+10.9%) |
| June 2013 | - | -$6.92 M(+63.3%) | -$17.29 M(+27.7%) |
| Mar 2013 | - | -$4.24 M(+52.7%) | -$13.53 M(+15.2%) |
| Dec 2012 | -$11.74 M(+8.5%) | -$2.78 M(-17.2%) | -$11.74 M(+31.0%) |
| Sept 2012 | - | -$3.35 M(+5.8%) | -$8.97 M(+59.7%) |
| June 2012 | - | -$3.17 M(+29.3%) | -$5.62 M(+129.3%) |
| Mar 2012 | - | -$2.45 M | -$2.45 M |
| Dec 2011 | -$10.82 M(-62.3%) | - | - |
| Dec 2002 | -$28.73 M(+15.2%) | - | - |
| Dec 2001 | -$24.93 M(-9.6%) | - | - |
| Dec 2000 | -$27.58 M(+158.4%) | - | - |
| Dec 1999 | -$10.67 M | - | - |
FAQ
- What is Esperion Therapeutics annual net profit?
- What is the all time high annual net income for Esperion Therapeutics?
- What is Esperion Therapeutics annual net income year-on-year change?
- What is Esperion Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly net income year-on-year change?
- What is Esperion Therapeutics TTM net profit?
- What is the all time high TTM net income for Esperion Therapeutics?
- What is Esperion Therapeutics TTM net income year-on-year change?
What is Esperion Therapeutics annual net profit?
The current annual net income of ESPR is -$209.25 M
What is the all time high annual net income for Esperion Therapeutics?
Esperion Therapeutics all-time high annual net profit is -$10.67 M
What is Esperion Therapeutics annual net income year-on-year change?
Over the past year, ESPR annual net profit has changed by +$24.41 M (+10.45%)
What is Esperion Therapeutics quarterly net profit?
The current quarterly net income of ESPR is -$29.52 M
What is the all time high quarterly net income for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly net profit is $124.61 M
What is Esperion Therapeutics quarterly net income year-on-year change?
Over the past year, ESPR quarterly net profit has changed by +$11.73 M (+28.43%)
What is Esperion Therapeutics TTM net profit?
The current TTM net income of ESPR is -$86.77 M
What is the all time high TTM net income for Esperion Therapeutics?
Esperion Therapeutics all-time high TTM net profit is -$2.45 M
What is Esperion Therapeutics TTM net income year-on-year change?
Over the past year, ESPR TTM net profit has changed by +$121.62 M (+58.36%)